Combining mannose receptor mediated nanovaccines and gene regulated PD-L1 blockade for boosting cancer immunotherapy

Tumor nanovaccines have potential applications in the prevention and treatment of malignant tumors. However, it remains a longstanding challenge in exploiting efficient nanocarriers for inducing potent specifically cellular immune responses. Toward this objective, we herein explore an intensive tumo...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jie, Fang, Huapan, Hu, Yingying, Wu, Jiayan, Zhang, Sijia, Feng, Yuanji, Lin, Lin, Tian, Huayu, Chen, Xuesi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: KeAi Publishing 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379363/
https://www.ncbi.nlm.nih.gov/pubmed/34466725
http://dx.doi.org/10.1016/j.bioactmat.2021.05.036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379363/
https://www.ncbi.nlm.nih.gov/pubmed/34466725
http://dx.doi.org/10.1016/j.bioactmat.2021.05.036

Ejemplares similares